View Older Stories View More Recent Stories
-
Citizens Starts Achieve Life Sciences (ACHV) at Market Outperform
-
OSB GROUP PLC - Transaction in Own Shares
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Ultragenyx to Participate in Investor Conferences in December
-
Helmerich & Payne (HP) PT Raised to $29 at Citi
-
LexinFintech Holdings (ADR) (LX) PT Lowered to $6.60 at Citi
-
AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE
-
Sana Biotechnology to Present at December 2025 Investor Conferences
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
François Du Pasquier Joins UBS as Managing Director, Financial Advisor in Austin
-
Form 424B2 CITIGROUP INC
-
Carter Announces Prospect Highland Oaks, a New 324-Unit Luxury Apartment Community in Tampa, FL
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Mexico's persistent core inflation fuels annual price rises in early November
-
Form 424B2 CITIGROUP INC
-
CTBC Bank USA CEO Noor Menai to Speak at the Financial Times’s Global Banking Summit
-
Oklo (OKLO) PT Raised to $95 at Citi
-
UBS Reiterates Neutral Rating on Citi (C) amid CFO Transition
-
Claritev Corporation Announces Participation at Upcoming Conferences
-
Trafigura's former top nickel trader denies he colluded on $600 million fraud
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
-
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami
-
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
-
QuidelOrtho To Participate In Upcoming Investor Conferences

